← Back to Patent Explorer
US4312879A Expired / Lapsed US ⏱️ 0.0 years remaining

Clonidine and lofexidine as antidiarrheal agents

Assignee: Richardson Vicks Inc
•
Filing: 1980-08-14
•
Granted: 1982-01-26
•
Expires: 2000-08-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Clonidine and lofexidine and the pharmaceutically acceptable salts thereof, which are, inter alia, known antihypertensives, also possess very potent antidiarrheal activity which is non-narcotic and more potent than that of conventional antidiarrheal drugs, such as diphenoxylate.

Inventors

  • 👤 Harbans Lal

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 07:55
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/04; C07D233/28; C07D233/44; C07D233/50; C07D233/06; C07D233/08; C07D233/12; C07D233/14

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 73 words
A method of alleviating the symptoms of diarrhea induced by a toxin, antigen, a general irritant or by the administration of an antibiotic, but excluding diarrhea induced by central nervious system disorders, in a patient not otherwise being treated with clonidine, lofexidine or an antihypertensive drug, comprising administering to such a patient an antidiarrheally-effective, non-antihypertensive amount of clonidine, lofexidine or a pharmaceutically acceptable salt thereof for a period of up to 4 days.
Claim 2
Independent Claim 73 words
A method of alleviating the symptoms of diarrhea induced by a toxin, antigen, a general irritant or by the administration of an antibiotic, but excluding diarrhea induced by central nervious system disorders, in a patient not otherwise being treated with clonidine, lofexidine or an antihypertensive drug, comprising administering to such a patient an antidiarrheally-effective, non-antihypertensive amount of clonidine, lofexidine or a pharmaceutically acceptable salt thereof for a period of up to 4 days.
Claim 3
Dependent Claim 12 words
The method of claim 1, wherein clonidine is administered to the patient.
Claim 4
Dependent Claim 12 words
The method of claim 1, wherein lofexidine is administered to the patient.
Claim 5
Dependent Claim 13 words
The method of claim 2, wherein clonidine is administered as its hydrochloride salt.
Claim 6
Dependent Claim 13 words
The method of claim 3, wherein lofexidine is administered as its hydrochloride salt.
Claim 7
Dependent Claim 15 words
The method of claim 2, wherein the dosage of clonidine is 0.1-0.4 mg per day.
Claim 8
Dependent Claim 15 words
The method of claim 3, wherein the dosage of lofexidine is 0.1-0.4 mg per day.
Claim 9
Dependent Claim 10 words
The method of claim 1, wherein the administration is oral.

References Cited (Backward Citations)

US3190802A Cited
US3202660A Cited
US3966757A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-01-25 1985-07-27 1986-01-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-01-25 1989-07-27 1990-01-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-01-25 1993-07-27 1994-01-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag